Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis.
Nicol M, Deney A, Lairez O, Vergaro G, Emdin M, Carecci A, Inamo J, Montfort A, Neviere R, Damy T, Harel S, Royer B, Baudet M, Cohen-Solal A, Arnulf B, Logeart D.
Nicol M, et al. Among authors: neviere r.
Eur J Heart Fail. 2021 Feb;23(2):231-239. doi: 10.1002/ejhf.2016. Epub 2020 Oct 22.
Eur J Heart Fail. 2021.
PMID: 33006180
Free article.